title: Capecitabine-induced terminal ileitis.
authors: Aboelkhair Mohammad
authors: AM
authors: Al-Gahmi
authors: Ian Graham
authors: IG
authors: Kerr
authors: Jamal Mohamed
authors: JM
authors: Zekri
authors: Abbas Abdulqader
authors: AA
authors: Zagnoon
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000069287:Capecitabine; D003113:Colonoscopy; D003424:Crohn Disease / Q000139:chemically induced* / Q000175:diagnosis; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007079:Ileitis / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D011355:Prodrugs; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000556:secondary
chemical_list: D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil
references: Ann Oncol. 2002 Apr;13(4):566-75
references: 12056707
references: Jpn J Clin Oncol. 2006 Jul;36(7):410-7
references: 16825251
references: Ned Tijdschr Geneeskd. 2011;155:A3064
references: 21486509
references: Eur J Cancer. 1998 Jul;34(8):1274-81
references: 9849491